ADJUNJA Trademark
ADJUNJA is a USPTO trademark filed by Seqirus UK Limited. Status: Registered.
Prosecution Summary
Trademark Summary
The mark ADJUNJA covers vaccines in International Class 005. It is owned by Seqirus UK Limited, a limited company organized under the laws of England and Wales. The mark is registered on the Principal Register since April 6, 2021, with registration number 6311755.
Recent Activity
Filed on September 13, 2019, the application faced a non-final office action in December 2019, response in January 2020, and approval for publication that month, followed by publication for opposition on March 3, 2020. A petition to change the filing basis to foreign registration was granted in December 2020, leading to republication on January 19, 2021, and registration on April 6, 2021.
Trademark Facts
| Mark | ADJUNJA |
|---|---|
| Serial Number | 88616459 |
| Registration Number | 6311755 |
| Status | Registered |
| Filing Date | 2019-09-13 |
| Registration Date | 2021-04-06 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | Seqirus UK Limited |
| Attorney of Record | Nancy Sabarra |
| Prosecution Events | 31 |
| Latest Event | REM1 on 2026-04-06 |
Goods & Services
Vaccines